Enzolytics, Inc. ENZC
0.00 USD 0.00 (+0.00%)
Nov 4, 2026, 1:55 PM EST
0.0004 Day range 0.0004
0.0002 52-week range 0.0013
- YTD
- +33.33%
- 1 year
- 0.00%
- Market cap
- 1.93M
- EPS (ttm)
- -0.26
- YTD return
- +33.33%
- 1-year return
- 0.00%
- Volume
- 723.13K
- Avg volume
- 3.51M
- Open
- 0.0004
- Previous close
- 0.0004
- Day's range
- 0.0004 – 0.0004
- 52-week range
- 0.0002 – 0.0013
YTD +0.0001 (+33.33%)
News
Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator 
Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement 
Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells 
Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications 
Enzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd. 
Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release 
Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment 
Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology 
Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment 
Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.
Your note
Sign in to keep a note on ENZC — it syncs with the Stock Master app.